| Beyond the Abstract - Saturation Technique Does Not Decrease Cancer Detection During Followup After Initial Prostate Biopsy |
|
|
|
|
|
| Tuesday, 22 April 2008 | ||
|
BERKELEY, CA (UroToday.com) - This is a good example of why we perform research and assess outcomes with hard data, because in the field of prostate biopsy, we have plenty of experience demonstrating that many of our assumptions, based on common sense alone, are ultimately proven wrong. In this example, over 5 years ago, our group found that our ability to perform saturation prostate biopsy in the office using local anesthetic was well tolerated. We also found no increase in bleeding, pain, infection, or other complications compared to sextant biopsy. Therefore, common sense said that we might as well use this as an initial biopsy strategy, in order to find all cancers on the first biopsy, instead of reserving for repeat biopsy. As it turns out, common sense was wrong, and we found that the detection rate was no higher in our hands when we used saturation biopsy as an initial biopsy strategy than it was when we did extended 10-12 core biopsies. The piece of the puzzle that the present report fills in is to allow us to know how many of these men would ultimately be found to have prostate cancer. In this report, we followed these men for 2-3 years and found that as many had a positive biopsy during repeat biopsy as we would expect following 12 core biopsy, putting a nail in the coffin for saturation biopsy as an initial biopsy. This doesn't detract from the value of saturation biopsy for repeat biopsy, and we continue to use it for all repeat biopsies based on detection rates that we have previously reported, and the tolerability that leaves no reason not to use it for repeat biopsy. Written by
UroToday.com Prostate Cancer Section read other Beyond The Abstract submissions More Information about Beyond the Abstract
Please log-in or register in order to submit comments. Powered by AkoComment! |
||
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2008 UroToday ® All Rights Reserved |









